Mydecine Innovations Group Revenue and Competitors

Denver, CO USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mydecine Innovations Group's estimated annual revenue is currently $620k per year.(i)
  • Mydecine Innovations Group's estimated revenue per employee is $155,000

Employee Data

  • Mydecine Innovations Group has 4 Employees.(i)
  • Mydecine Innovations Group grew their employee count by -33% last year.

Mydecine Innovations Group's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35483%$25MN/A
#2
$2M1318%N/AN/A
#3
$3.4M2210%N/AN/A
#4
$68M439-3%N/AN/A
#5
$2M1330%N/AN/A
#6
$4M268%N/AN/A
#7
$2.7M35-10%$23.2MN/A
#8
$5.3M3470%N/AN/A
#9
$1.7M11-8%N/AN/A
#10
$3.1M20-17%N/AN/A
Add Company

What Is Mydecine Innovations Group?

Mydecine Innovations Group™ (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a life sciences company dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing wellbeing. The company’s world-renowned medical and scientific advisory board is building out a robust R&D pipeline of nature-sourced psychedelic-assisted therapeutics, novel compounds, therapy protocols, and unique delivery systems. Mydecine has exclusive access to a full cGMP certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds with full government approval through Health Canada. Mydecine also operates out of a state-of-the-art mycology lab in Denver, CO to focus on genetic research for scaling commercial cultivation of rare (non-psychedelic) medicinal mushrooms.

keywords:N/A

N/A

Total Funding

4

Number of Employees

$620k

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M4-43%N/A
#2
$0.3M4N/AN/A
#3
$0.3M4N/AN/A
#4
$0.3M4N/AN/A
#5
$0.3M4N/AN/A